Related Experiment Videos
Laboratory results that predict arterial thrombosis
1Coagulation Service of the University of Alabama at Birmingham Hospital, USA. gfritsma@mindspring.com
Summary
Predicting cardiovascular disease risk involves laboratory tests like fibrinogen, homocysteine, and high-sensitivity C-reactive protein. These markers aid in assessing patient risk for better cardiovascular health management.
Area of Science:
- Clinical Chemistry
- Cardiovascular Medicine
- Laboratory Diagnostics
Background:
- Cardiovascular disease (CVD) remains a leading cause of mortality worldwide.
- Accurate risk prediction is crucial for timely intervention and prevention strategies.
- Laboratory markers play a vital role in assessing an individual's CVD risk profile.
Purpose of the Study:
- To review currently available laboratory market tests for cardiovascular disease risk prediction.
- To highlight key biomarkers frequently utilized in CVD risk assessment.
- To provide a brief overview of cardiovascular disease itself.
Main Methods:
- Literature review of laboratory tests for cardiovascular disease risk.
- Focus on three commonly ordered tests: fibrinogen, homocysteine, and high-sensitivity C-reactive protein.
- Expert descriptions and reviews of each biomarker's role in risk prediction.
Main Results:
- Fibrinogen is a significant predictor of cardiovascular events.
- Homocysteine levels are associated with an increased risk of cardiovascular disease.
- High-sensitivity C-reactive protein (hs-CRP) serves as an important marker for inflammation and CVD risk.
Conclusions:
- Laboratory testing provides valuable tools for predicting cardiovascular disease risk.
- Fibrinogen, homocysteine, and hs-CRP are key biomarkers for risk stratification.
- Understanding these markers aids in proactive cardiovascular health management.